Durability of response in ZUMA-1, the pivotal phase 2 study of axicabtagene ciloleucel (Axi-Cel) in patients (Pts) with refractory large B-cell lymphoma.
暂无分享,去创建一个
D. Miklos | E. Jacobsen | C. Jacobson | L. Lekakis | J. Rossi | S. Neelapu | F. Locke | I. Braunschweig | O. Oluwole | T. Siddiqi | Yi Lin | A. Deol | U. Farooq | A. Ghobadi | P. Reagan | A. Bot | Yi-zhou Jiang | W. Go | A. Xue